Amedisys Q4 2023 Adj EPS $0.94 Misses $1.03 Estimate, Sales $570.80M Beat $567.71M Estimate
Portfolio Pulse from Benzinga Newsdesk
Amedisys reported Q4 2023 earnings of $0.94 per share, missing the consensus estimate of $1.03 by 8.74%. However, their quarterly sales of $570.80 million exceeded the estimate of $567.71 million by 0.54%, marking a 1.55% increase from the previous year.
February 21, 2024 | 10:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amedisys missed Q4 2023 EPS estimates but exceeded revenue forecasts, showing a mixed financial performance.
Missing the EPS estimate could negatively impact investor sentiment, while beating sales forecasts might offset some of the negative impact. The mixed results present a neutral outlook for the stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100